P16 methylation leads to paclitaxel resistance of advanced ...

P16, methylation, paclitaxel, resistance, non-small cell lung cancer. Running title: LIU et al: P16 METHYLATION SERVES AS A PREDICT BIOMARKER FOR PACLITAXEL RESISTANCE IN NSCLC Abstract. Paclitaxel-based chemotherapy is widely used as the first-line treatment for non-small cell lung cancer (NSCLC). ................
................